Firma en Digital.CSIC (*)
Castro, Sonia de
 
Centro o Instituto
CSIC - Instituto de Quimica Medica (IQM)
 
 
WoS ResearcherID - Publons
 
 

Publications
(Artículos)

Resultados 1-8 de 8.

DerechosPreviewFecha Public.TítuloAutor(es)Tipo
1closedAccessaccesoRestringido.pdf.jpg20084″-benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral actionCastro, Sonia de CSIC ORCID ; Peromingo, M. T.; Naesens, L.; Andrei, G.; Snoeck, R.; Balzarini, J.; Velázquez, Sonsoles CSIC ORCID CVN; Camarasa Rius, María José CSIC ORCIDartículo
2openAccess2006Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profileCastro, Sonia de CSIC ORCID ; García-Aparicio, Carlos CSIC; Van Laethem, K.; Gago, Federico CSIC ORCID; Lobatón, E.; De Clercq, E.; Balzarini, J.; Camarasa Rius, María José CSIC ORCID; Velázquez, Sonsoles CSIC ORCID CVNartículo
3openAccess2005Novel [2′,5′-Bis-O-(tert-butyldimethylsily)-β-D- ribofuranosyl]-3′-spiro-5″-(4″-amino-1″, 2″-oxathiole-2″,2″-diozide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activityCastro, Sonia de CSIC ORCID ; Lobatón, E.; Peréz-Pérez, María-Jesús CSIC ORCID ; San-Félix, Ana CSIC ORCID ; Cordeiro, A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J.; Camarasa Rius, María José CSIC ORCID; Velázquez, Sonsoles CSIC ORCID CVNartículo
4closedAccessaccesoRestringido.pdf.jpg2007NOVEL NON-NUCLEOSIDE HUMAN CYTOMEGALOVIRUS INHIBITORS BASED UPON TSAO NUCLEOSIDE DERIVATIVES:STRUCTURE-ACTIVITY RELATIONSHIPSCastro, Sonia de CSIC ORCID ; Andrei, Graziela; Snoeck, Robert; Balzarini, Jan; Camarasa Rius, María José CSIC ORCID; Velázquez, Sonsoles CSIC ORCID CVNartículo
5closedAccessaccesoRestringido.pdf.jpg2008Reactivity of the 4-amino-5H-1,2-oxathiole-2,2-dioxide heterocyclic system: A combined experimental and theoretical studyCastro, Sonia de CSIC ORCID ; Peromingo, M. T.; Lozano, Ángel E. ; Camarasa Rius, María José CSIC ORCID; Velázquez, Sonsoles CSIC ORCID CVNartículo
6closedAccessaccesoRestringido.pdf.jpg2005The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugsAuwerx, J.; Van Nieuwenhove, J.; Rodríguez-Barrios, F.; Castro, Sonia de CSIC ORCID ; Velázquez, Sonsoles CSIC ORCID CVN; Ceccherini-Silberstein, F.; De Clercq, E.; Camarasa Rius, María José CSIC ORCID; Perno, C.-F.; Gago, Federico CSIC ORCID; Balzarini, J.artículo
7closedAccessaccesoRestringido.pdf.jpg2006TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: Recent progressCamarasa Rius, María José CSIC ORCID; Velázquez, Sonsoles CSIC ORCID CVN; San-Félix, Ana CSIC ORCID ; Peréz-Pérez, María-Jesús CSIC ORCID ; Bonache, María-Cruz CSIC; Castro, Sonia de CSIC ORCID artículo de revisión
8openAccess2006Unprecedented lability of the 5′-O-tert-butyldimethylsilyl group from 3′-spiro-5″-(4″-acylamino-1″,2″-oxathiole- 2″,2″-dioxide) nucleoside derivatives via neighboring group participation of the 4″-acylamino residueCastro, Sonia de CSIC ORCID ; Lozano, Ángel E. ; Jimeno, M. Luisa CSIC ORCID; Peréz-Pérez, María-Jesús CSIC ORCID ; San-Félix, Ana CSIC ORCID ; Camarasa Rius, María José CSIC ORCID; Velázquez, Sonsoles CSIC ORCID CVNartículo